You are here: Industry Insights > Lilly

News List

Lilly and Sigilon to collaborate on cell encapsulation for diabetes pharmaceutical-technolog
April 09, 2018
Eli Lilly and Sigilon Therapeutics have announced a strategic collaboration to develop encapsulated cell therapies for type 1 diabetes.
Terns Acquires Rights to Develop, Commercialize Three NASH Assets from Lilly americanpharmaceuticalreview
April 09, 2018
Terns Pharmaceuticals has signed a global, exclusive license agreement with Eli Lilly and Company to develop, manufacture and commercialize three small molecule therapeutic candidates
Lilly, Sigilon Therapeutics Announce Collaboration americanpharmaceuticalreview
April 09, 2018
Eli Lilly and Company and Sigilon Therapeutics announced a global collaboration to develop encapsulated cell therapies for the potential treatment of type 1 diabetes
Lilly Receives Additional FDA Approval for Verzenio Americanpharmaceuticalreview
February 28, 2018
Eli Lilly and Company announced that the U.S. Food and Drug Administration (FDA) has approved Verzenio (abemaciclib) in combination with an aromatase inhibitor (AI) ...
J&J, Lilly and AZ diabetes medications get another helping of real-world heart benefits fiercepharma
November 23, 2017
Last year, real-world data showed that SGLT2 diabetes drugs could significantly cut heart failure hospitalizations and all-cause deaths.
Lilly used nursing services as kickbacks to boost insulin prescriptions, lawsuit claims fiercepharma
November 17, 2017
After Novo Nordisk settled a lawsuit alleging it marketed certain drugs under a "white coat" sales scheme, fellow diabetes drug giant Eli Lilly is facing similar claims of illicit marketing.
Lilly used nursing services as kickbacks to boost insulin prescriptions, lawsuit claims fiercepharma
November 17, 2017
After Novo Nordisk settled a lawsuit alleging it marketed certain drugs under a "white coat" sales scheme, fellow diabetes drug giant Eli Lilly is facing similar claims of illicit marketing
Trump poised to nominate ex-Lilly executive Alex Azar for top HHS job: report fiercepharma
November 10, 2017
Despite blasting pharma for "getting away with murder" on multiple occasions, President Donald Trump is expected to pick a former pharmaceutical executive to lead the Department of Health and Human Services, Bloomberg reports.
Eli Lilly announces an investment of US$72 million in core business pharmaasia
November 01, 2017
The company has a nine decade legacy of researching and producing the drug.
Lilly considering spinning out or entirely selling the animal health business pharmafile
October 26, 2017
Eli Lilly released its Q3 financials and the major talking point was the announcement that the business was reviewing “strategic alternatives” for its Elanco Animal Health unit.

Previous page 1 2 3 4 5 6 7 8 9 10 ... 25 26 Next page